Keywords: fda, fast, track, cell, genesys, gvax, food

FDA fast track for Cell Genesys' GVAX

Article | 15 May 2006

Print This

The US Food and Drug Administration (FDA) has granted fast-track designation for Cell Genesys' GVAX immunotherapy, the company's lead product ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in